Paclitaxel, Epirubicin and Cyclophosphamide Combination in First-Line Treatment of Metastatic Breast Cancer: A Dose Escalation Study

Publisher： Karger

E-ISSN： 1423-0232|66|3|185-191

ISSN： 0030-2414

Source： Oncology, Vol.66, Iss.3, 2004-06, pp. : 185-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

First-Line Monochemotherapy with Mitoxantroneversus Combination with Fluorouracil, Epirubicin and Cyclophosphamide in High-Risk Metastatic Breast Cancer: A Prospective Randomized Multicenter Clinical Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 1, 2000-03 ,pp. : 54-59

Karger

Access to resources Recommend Favorite

Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer

By Sherrill Beth   Di Leo Angelo   Amonkar Mayur M.   Wu Yun   Zvirbule Zanete   Aziz Zeba   Bines Jose   Gomez Henry L.  

Current Medical Research and Opinion, Vol. 26, Iss. 4, 2010-04 ,pp. : 767-775

Informa Healthcare

Access to resources Recommend Favorite

Dose-Finding Phase I and Pharmacokinetic Study of Capecitabine (Xeloda) in Combination with Epirubicin and Cyclophosphamide (CEX) in Patients with Inoperable or Metastatic Breast Cancer

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 330-337

Karger

Access to resources Recommend Favorite

Phase II Trial of Pegylated Liposomal Doxorubicin-Cyclophosphamide Combination as First-Line Chemotherapy in Older Metastatic Breast Cancer Patients

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 210-214

Karger

Access to resources Recommend Favorite

A Single-Arm Phase II Trial of First-Line Paclitaxel in Combination with Lapatinib in HER2-Overexpressing Metastatic Breast Cancer

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 129-135

Karger

Access to resources Recommend Favorite